Orthopaedic Surgery Department, Westchester Medical Center, New York Medical College, Valhalla, New York, USA.
J Arthroplasty. 2013 Feb;28(2):234-242.e1. doi: 10.1016/j.arth.2012.05.010. Epub 2012 Jul 17.
Despite clinical success, it is unclear which one, posterior-substituting (PS) or cruciate-retaining (CR) insert, has superior functional outcomes or longevity. We compared the collected results from 2 institutional review board-approved, multicenter, prospective observational studies following CR (412) and PS inserts (328). Participants were evaluated preoperatively, at 6 weeks, at 3 months, and at 1 and 2 years regarding pain, motion, function (Knee Society Score, Krackow Activity Score, Short Form-36), and procedure variables such as anesthesia and preoperative/perioperative/postoperative complications. Implant longevity was recorded at the 2-year follow-up. Improvement was observed within each group; however, there was no difference between groups in terms of pain, motion, or function at any end point. Two-year survival rate was higher than 95%. A higher incidence of wound hematoma was observed in the PS group. Both inserts can be used expecting satisfactory outcomes and high survival rates at 2 years.
尽管临床效果显著,但目前尚不清楚哪种后稳定型(PS)或前交叉韧带保留型(CR)植入物在功能结果或寿命方面更具优势。我们比较了 2 项经机构审查委员会批准的、多中心、前瞻性观察研究的结果,这两项研究分别随访了 CR 植入组(412 例)和 PS 植入组(328 例)。在术前、术后 6 周、3 个月、1 年和 2 年,我们对患者的疼痛、活动度、功能(膝关节协会评分、Krackow 活动评分、36 项简明健康调查)以及麻醉和术前/围手术期/术后并发症等手术变量进行了评估。在 2 年随访时记录了植入物的使用寿命。每组患者均有改善,但在任何终点,两组患者的疼痛、活动度或功能均无差异。2 年生存率高于 95%。PS 组观察到更高的伤口血肿发生率。两种植入物都可以使用,预计在 2 年内可获得满意的结果和高生存率。